SRF Q1: consolidated PAT surges 76% YoY to ₹759 Cr as films and chemicals drive margin jump
PAT +75.53% YoY · revenue +31.81% · margins expanding
₹5,033.26 Cr
+31.81% YoY
₹758.87 Cr
+75.53% YoY
14.98%
+3.7pp YoY
₹25.6
SRF opened FY27 with a materially stronger-than-base print: consolidated revenue of ₹5,033 Cr rose 31.8% YoY (9.1% QoQ) and net profit jumped 75.5% YoY to ₹758.9 Cr (30.4% QoQ), lifting basic EPS to ₹25.60 from ₹14.58 a year ago. Crucially there was no exceptional item this quarter and none in the year-ago Q1 either, so the near-76% growth is entirely operational — not an accounting artefact. Net profit margin expanded to 15.08% from 11.32% YoY and operating margin to 20.82% from 17.17%, a broad-based margin lift across all three segments.
Q1 FY-2027 vs prior quarters
The standout driver was the Performance Films & Foil Business, whose consolidated segment result leapt to ₹349.7 Cr from ₹140.2 Cr (+150% YoY) on revenue of ₹2,016.7 Cr (+42%) — the overseas packaging-films subsidiaries did the heavy lifting, contributing ₹171 Cr of net profit before consolidation. Chemicals, the core, delivered revenue of ₹2,314.9 Cr (+26% YoY) and a segment result of ₹638.4 Cr (+27%), confirming the agrochem/fluorochem recovery management flagged on the January concall; Technical Textiles also nearly trebled its result to ₹107.8 Cr. This is where basis matters: standalone PAT of ₹566.3 Cr grew a more modest 42.6% YoY, so the consolidated story is far stronger than the parent's alone — readers will see both numbers and the gap is the overseas films business, not a discrepancy.
The stock went into the print at ₹2,865, up 5.3% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
SRF expects FY26 capex to be on track for INR2,200-2,300 crore, with a strong FY27 capex forecast of INR1,500-2,000 crore for the initial phase of new generation gas plants at the Odisha site. A second pharma intermediate plant, a non-CGMP facility with an investment of INR180 crore, is slated for commissioning within
— This quarter: beat
Against management's own framing the quarter beats: the prior concall guided to Chemicals growing 15-20% in FY27 and a Q4-onward recovery amid persistent Chinese pricing pressure, and Q1 chemicals revenue up 26% already runs ahead of that. No formal quarterly P&L guidance is given by the company and no brokerage consensus number surfaced for this specific quarter, so a street beat/miss can't be quantified. Alongside the result the board declared a first FY27 interim dividend of ₹5/share (₹148.21 Cr). The main question the print leaves open is durability — the PFB result more than doubled YoY off a favourable films cycle, and management's own caution on specialty-chemical pricing means the margin bridge needs to hold, not just print once.
W1
Chemicals FY27 growth guidance of 15-20% — Q1 already at +26% YoY; watch specialty-chemical pricing vs continued Chinese pressure
W2
PFB result run-rate: ₹349.7 Cr (+150% YoY) off a strong films cycle — verify the margin holds into H2
W3
Odisha new-generation refrigerant gas plants — FY27 initial-phase capex of ₹1,500-2,000 Cr; commissioning cadence
Clean digital filing; both statements present, headers unambiguous, all arithmetic ties. No exceptional item this quarter (nil) NOR in the year-ago Q1 FY26 — YoY growth is fully underlying. Prior QoQ base (Q4 FY26) carried an 11.71 Cr labour-code exceptional loss, so QoQ PAT growth is marginally overstated. Consolidated tax = current 172.40 + deferred 47.88.
Informational and educational content only. Not investment advice.